InvestorsHub Logo
Followers 2
Posts 153
Boards Moderated 0
Alias Born 11/13/2016

Re: Whalatane post# 246979

Tuesday, 02/18/2020 4:52:31 PM

Tuesday, February 18, 2020 4:52:31 PM

Post# of 429484
“In a worst case scenario of Vascepa losing exclusivity immediately, we believe pricing would be almost 100% maintained,” Beatty argued.
I believe he made this supposition based on V compared to the price of generic Lovaza. If true, he’s an idiot. Regardless, there is no way the initial reaction to patent loss would be negligible.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News